CLL Support Association

ASCO 2014: Dr. Sharman on single agent obinituzumab

Hi friends,

More information on single agent obinituzumab AKA GA101 AKA Gazyva and CLL from ASCO 2014 on my blog:

I am posting all the audio interviews. The future looks bright. I have been working hard on a plan to build what needed to fill the yet unmet needs of the CLL community.

More soon.

Stay strong. We are all in this together.



You may also like...